# DEXTENZA

NDC: 70382-204
Generic name: dexamethasone
Labeler / Manufacturer: Ocular Therapeutix, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INSERT
Routes: INTRACANALICULAR, OPHTHALMIC
Marketing started: 20190107

FDA application: NDA208742

## Active ingredients

- DEXAMETHASONE: .4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70382-204"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70382-204
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7514e6b8-c33f-4fbf-8810-ef520e1eb4bd